Clover Health Investments (CLOV)
NASDAQ:CLOV
CLOV Stock Chart & Stats
$1.93
-$0.09(-2.50%)
At close: 4:00 PM EST
$1.93
-$0.09(-2.50%)
Day’s Range― - ―
52-Week Range$1.58 - $3.92
Previous CloseN/A
Volume2.53M
Average Volume (3M)5.47M
Market Cap
$1.01B
Enterprise Value$909.82M
Total Cash (Recent Filing)$95.35M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.60
Next Earnings
May 06, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding428,951,420
10 Day Avg. Volume5,179,938
30 Day Avg. Volume5,473,232
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)3.94
Price to Sales (P/S)0.63
P/FCF Ratio-17.62
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue0.47
Enterprise Value/Gross Profit2.56
Enterprise Value/Ebitda-10.85
Forecast
1Y Price Target
$2.98Price Target Upside54.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.02
Revenue Forecast (FY)$2.88B
Bulls Say, Bears Say
Bulls Say
Clinical Technology ImpactWidespread physician adoption of the Clover Assistant is associated with lower medical cost ratios and improved documentation, which can enhance unit economics for members who switch plans.
Membership Growth And RetentionVery high member retention and concentrated growth in Medicare Advantage PPO markets with strong physician engagement supports revenue scale and improves margins as new members stabilize.
Profitability GuidanceGuidance targeting GAAP net income profitability combined with demonstrated ability to absorb large membership inflows without sacrificing profits signals a clearer path to sustainable earnings.
Bears Say
Guidance And Analyst CautionAnalysts maintaining conservative profitability estimates until formal guidance is issued may temper investor expectations and increase stock volatility while visibility remains limited.
Regulatory Rate Notice UncertaintyDisappointing Medicare Advantage rate notices from regulators introduce uncertainty around future margins and complicate forecasting of earnings.
Reimbursement And Star-rating RiskPotential reversion to a lower star payment level and weak Medicare Advantage rate updates could reduce revenue per member and put pressure on profitability.
Clover Health Investments News
CLOV FAQ
What was Clover Health Investments’s price range in the past 12 months?
Clover Health Investments lowest stock price was $1.58 and its highest was $3.92 in the past 12 months.
What is Clover Health Investments’s market cap?
Clover Health Investments’s market cap is $1.01B.
When is Clover Health Investments’s upcoming earnings report date?
Clover Health Investments’s upcoming earnings report date is May 06, 2026 which is in 23 days.
How were Clover Health Investments’s earnings last quarter?
Clover Health Investments released its earnings results on Feb 26, 2026. The company reported -$0.051 earnings per share for the quarter, beating the consensus estimate of -$0.102 by $0.051.
Is Clover Health Investments overvalued?
According to Wall Street analysts Clover Health Investments’s price is currently Undervalued.
Does Clover Health Investments pay dividends?
Clover Health Investments does not currently pay dividends.
What is Clover Health Investments’s EPS estimate?
Clover Health Investments’s EPS estimate is 0.07.
How many shares outstanding does Clover Health Investments have?
Clover Health Investments has 428,951,420 shares outstanding.
What happened to Clover Health Investments’s price movement after its last earnings report?
Clover Health Investments reported an EPS of -$0.051 in its last earnings report, beating expectations of -$0.102. Following the earnings report the stock price went down -2.791%.
Which hedge fund is a major shareholder of Clover Health Investments?
Currently, no hedge funds are holding shares in CLOV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clover Health Investments Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.98 (54.40% Upside)
$2.98 (54.40% Upside)
Blogger Sentiment
Bullish
CLOV Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $379.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.9%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.41%
12-Months-Change
Fundamentals
Return on Equity
-25.73%
Trailing 12-Months
Asset Growth
-6.84%
Trailing 12-Months
Company Description
Clover Health Investments
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
CLOV Company Deck
CLOV Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized significant positive momentum: robust membership and revenue growth, adjusted EBITDA profitability in 2025, strong retention and technology adoption, and guidance targeting the company’s first full year of GAAP net income in 2026. Key risks highlighted include first-year new-member dilution (reflected in a higher BER and $145 PMPM new member contribution loss), outpatient and Part D cost pressures, abnormal dental/DME activity that required remediation, and near-term operating cash use. Management presented clear plans and structural drivers (cohort maturation, Clover/Counterpart Assistant expansion, 4-star payment tailwind, and SG&A leverage) to improve margins and convert growth into sustainable GAAP profitability.View all CLOV earnings summariesCLOV Stock 12 Month Forecast
Average Price Target
$2.98
▲(54.40% Upside)
Technical Analysis
Ownership Overview
6.51% Insiders
7.73% Mutual Funds
0.68% Other Institutional Investors
75.05% Public Companies and
Individual Investors